Increased platelet reactivity in patients given Orbofiban after an acute coronary syndrome:: An OPUS-TIMI 16 substudy

被引：75

作者：

Holmes, MB

Sobel, BE

Cannon, CP

Schneider, DJ

机构：

[1] Univ Vermont, Coll Med, Cardiol Unit, Dept Med, Burlington, VT 05401 USA

[2] Brigham & Womens Hosp, Cambridge, MA USA

[3] Harvard Univ, Sch Med, Cambridge, MA 02138 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2000年 / 85卷 / 04期

关键词：

D O I：

10.1016/S0002-9149(99)00778-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The results of the present study underscore the potential value of the use of sensitive assays of specific aspects of platelet function for identifying and quantifying changes in platelet reactivity after initiation of therapy with antiplatelet agents. Implementation of such assays could contribute to optimal design and performance of clinical trials of antiplatelet agents as well as treatment of patients with acute coronary syndromes.

引用

页码：491 / 493

页数：3

共 13 条

[1] Platelet activation in patients after an acute coronary syndrome: Results from the TIMI-12 trial [J].

Ault, KA ;

Cannon, CP ;

Mitchell, J ;

McCahan, J ;

Tracy, RP ;

Novotny, WF ;

Reimann, JD ;

Braunwald, E .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (03) :634-639

[2]

Bazzino O, 1998, NEW ENGL J MED, V338, P1488

[3] USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].

CALIFF, RM ;

SHADOFF, N ;

VALETT, N ;

BATES, E ;

GALEANA, A ;

KNOPF, W ;

SHAFTEL, J ;

BENDER, MJ ;

AVERSANO, T ;

RAQUENO, J ;

GURBEL, P ;

COWFER, J ;

COHEN, M ;

CROSS, P ;

BITTL, J ;

EDDINGS, K ;

TAYLOR, M ;

DEROSA, K ;

HATTEL, L ;

COOPER, L ;

ESHELMAN, B ;

FINTEL, D ;

NIEMYSKI, P ;

KLEIN, L ;

KENNEDY, H ;

THORNTON, T ;

KEREIAKES, D ;

MARTIN, L ;

ANDERSON, L ;

HIGBY, N ;

ELLIS, S ;

BREZINA, K ;

GEORGE, B ;

CHAPEKIS, A ;

SMITH, D ;

ANWAR, A ;

GERBER, TL ;

PRITCHARD, GL ;

MYLER, R ;

SHAW, R ;

MURPHY, M ;

WARD, K ;

MADIGAN, NP ;

BLANKENSHIP, J ;

HALBERT, M ;

FLANAGAN, C ;

TANNENBAUM, M ;

POLICH, M ;

STEVENSON, C ;

TCHENG, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961

[4] The lack of augmentation by aspirin of inhibition of platelet reactivity by Ticlopidine [J].

Farrell, TP ;

Hayes, KB ;

Sobel, BE ;

Schneider, DJ .

AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (05) :770-774

[5]

Ferguson JJ, 1999, CIRCULATION, V100, P570, DOI 10.1161/01.CIR.100.6.570

[6]

FRELINGER AL, 1991, J BIOL CHEM, V266, P17106

[7] Differences between activation thresholds for platelet P-selectin and glycoprotein IIb-IIIa expression and their clinical implications [J].

Holmes, MB ;

Sobel, BE ;

Howard, DB ;

Schneider, DJ .

THROMBOSIS RESEARCH, 1999, 95 (02) :75-82

[8] Variable responses to inhibition of fibrinogen binding induced by Tirofiban and Eptifibatide in blood from healthy subjects [J].

Holmes, MB ;

Sobel, BE ;

Schneider, DJ .

AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (02) :203-207

[9] Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (αIIbβ3) inhibitors [J].

Peter, K ;

Schwarz, M ;

Ylänne, J ;

Kohler, B ;

Moser, M ;

Nordt, T ;

Salbach, P ;

Kübler, W ;

Bode, C .

BLOOD, 1998, 92 (09) :3240-3249

[10] Blood clotting in minimally altered whole blood [J].

Rand, MD ;

Lock, JB ;

vantVeer, C ;

Gaffney, DP ;

Mann, KG .

BLOOD, 1996, 88 (09) :3432-3445

← 1 2 →